The regulation of vascular smooth muscle cell apoptosis

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 747-755

  McCarthy, Nicola J ^a   Bennett, Martin ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Apoptosis; Arteries; Atherosclerosis; Smooth muscle

Indexed keywords

ADAPTOR PROTEIN; CASPASE; CELL RECEPTOR; CYTOKINE; FAS ANTIGEN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

ANEURYSM; APOPTOSIS; ARTERY INJURY; ATHEROSCLEROSIS; CELL PROLIFERATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ARTERIOSCLEROSIS; CASPASES; CELLS, CULTURED; FAS LIGAND PROTEIN; HOMEOSTASIS; HUMANS; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0033964820     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00275-8     Document Type: Review

References (107)

1. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 87:1990;4600-4604.
2. Slomp J., Gittenberger-de Groot A.C., Glukhova M.A., et al. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol. 17:1997;1003-1009.
3. Cho A., Langille B.L. Arterial smooth-muscle cell turnover during the postnatal-period in lambs. Faseb J. 7:1993;A756-A756.
4. Cho A., Courtman D., Langille L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 76:1995;168-175.
5. Cho A., Mitchell L., Koopmans D., Langille B.L. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 81:1997;328-337.
6. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 17:1997;2238-2244.
7. Vega F., Panizo A., Toledo G., et al. Susceptibility to apoptosis of vascular smooth muscle cells of adult spontaneously hypertensive rats. Lab Invest. 78:1998;187-187.
8. Hamet P., Richard L., Dam T., et al. Apoptosis in target organs of hypertension. Hypertension. 26:1995;642-648.
9. Sharifi A.M., Schiffrin E.L., Iwashina M., et al. Apoptosis in vasculature of spontaneously hypertensive rats - Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am. J. Hypertension. 11:1998;1108-1116.
10. deBlois D., Tea B.S., Dam T.V., Tremblay J., Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 29:1997;340-349.
11. Cowan K.N., Jones P.L., Rabinovitch M. Serine elastase and matrix metalloproteinase (MMP) inhibition induces pulmonary artery (PA) smooth muscle cell (SMC) apoptosis leading to regression of vascular hypertrophy. Molecul Biol Cell. 8:1997;1661-1661.
12. Perlman H., Maillard L., Krasinski K., Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 95:1997;981-987.
13. Pollman M.J., Hall J.L., Mann M.J., Zhang L.N., Gibbons G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 4:1998;222-227.
14. Pollman M.J., Hall J.L., Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury - Influence of redox state and cell phenotype. Circ. Res. 84:1999;113-121.
15. Malik N., Francis S.E., Holt C.M., et al. Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation. 98:1998;1657-1665.
16. Bochatonpiallat M., Gabbiani F., Redard M., Desmouliere A., Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 146:1995;1059-1064.
17. Isner J., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
18. Bauriedel G., Schluckebier S., Hutter R., et al. Apoptosis in restenosis versus stable-angina atherosclerosis. Art Thromb. 18:1998;1132-1139.
19. Lopez Candales A., Holmes D.R., Liao S.X., et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am. J. Path. 150:1997;993-1007.
20. Thompson R.W., Liao S.X., Curci J.A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis. 8:1997;623-631.
21. Henderson E.L., Gang Y.J., Sukhova G.K., et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 99:1999;96-104.
22. Han D., Haudenschild C., Hong M., et al. Evidence for apoptosis in human atherosclerosis and in a rat vascular injury model. Am J Pathol. 147:1995;267-277.
23. Geng Y., Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β converting enzyme. Am J Pathol. 147:1995;251-266.
24. Kockx M.M. Apoptosis in the atherosclerotic plaque-Quantitative and qualitative aspects. Art Thromb Vascul Biol. 18:1998;1519-1522.
25. Boyle J., Bennett M., Proudfoot D., Bowyer D., Weissberg P. Human monocyte/macrophages induce human vascular smooth muscle cell apoptosis in culture. J Pathol. 184:1998;A13-A13.
26. Geng Y., Wu Q., Muszynski M., Hansson G., Libby P. Apoptosis of vascular smooth-muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor alpha, and interleukin-1-beta. Art Thromb Vascul Biol. 16:1996;19-27.
27. Hasdai D., Sangiorgi G., Spagnoli L.G., et al. Coronary artery apoptosis in experimental hypercholesterolemia. Atherosclerosis. 142:1999;317-325.
28. Sata M., Perlman H.R., Muruve D.A., et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA. 95:1998;1213-1217.
29. Mintz G., Popma J., Pichard A., et al. Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation. 94:1996;35-43.
30. Flynn P., Byrne C., Baglin T., Weissberg P., Bennett M. Thrombin generation by apoptotic vascular smooth muscle cells. Blood. 89:1997;4373-4384.
31. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429-2442.
32. Mallat Z., Benamer H., Hugel B., et al. Elevated plasma levels of shed membrane microparticles in patients with acute coronary syndromes. Circulation. 98:1998;I-172. (Abstract).
33. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques - A role for apoptosis in plaque thrombogenicity. Circulation. 99:1999;348-353.
34. Schaub F., Coats S., Seifert R., et al. Regulated overexpression of the Fas-associated Death Domain (FADD) protein in seeded vascular smooth muscle cells causes apoptosis followed by recruitment of macrophages. Circulation. 98:1998;I-597. (Abstract).
35. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull. 53:1997;491-508.
36. Sambrano G.R., Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidised low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc Natl Acad Sci USA. 92:1995;1396-1400.
37. Brown S.B., Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol. 162:1999;480-485.
38. Bennett M.R., Boyle J.J. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 138:1998;3-9.
39. Bennett M. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 41:1999;361-368.
40. Ashkenazi A., Dixit V. Death receptors: Signalling and modulation. Science. 281:1998;1305-1308.
41. Chinnaiyan A., O'Rourke K., Tewari M., Dixit V. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell. 81:1995;505.
42. Chinnaiyan A., Tepper C., Seldin M., et al. FADD/mort1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor induced apoptosis. J Biol Chem. 271:1996;4961-4965.
43. Stanger B.Z., Leder P., Lee T.H., Kim E., Seed B. Rip - a novel protein containing a death domain that interacts with Fas/Apo-1 (Cd95) in yeast and causes cell-death. Cell. 81:1995;513-523.
44. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J. 326:1997;1-16.
45. Muzio M., Chinnaiyan A., Kischkel F., et al. FLICE, a novel FADD-homologous ice/ced-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell. 85:1996;817-827.
46. Fernandes-Alnemri T., Litwack G., Alnemri E. Mch2, a new member of the apoptotic ced-3/ice cysteine protease gene family. Cancer Res. 55:1995;2737-2742.
47. Enari M., Talanian R., Wong W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
48. Srinivasula S., Ahmad M., Fermandes-Alnemri T. Litwack, G and Alnemri, E. Molecular ordering of the fas-apoptotic pathway: the fas/APO-1 protease mch-5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA. 93:1996;14486-14491.
49. Muzio M., Salvesen G.S., Dixit V.M. FLICE induced apoptosis in a cell-free system - Cleavage of caspase zymogens. J Biol Chem. 272:1997;2952-2956.
50. Takahashi A., Hirata H., Yonehara S., et al. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene. 14:1997;2741-2752.
51. Dixit V. The cell-death machine. Curr Biol. 6:1996;555-562.
52. Krammer P. The CD95 (Apo-1/Fas) receptor/ligand system-death signals and diseases. Cell Death Differ. 3:1996;159-160.
53. Enari M., Sakahira H., Yokoyama H., et al. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature. 391:1998;43-50.
54. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 273:1998;9357-9360.
55. Hirata H., Takahashi A., Kobayashi S., et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 187:1998;587-600.
56. Scaffidi C., Fulda S., Srinivasan A., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
57. Li H.L., Zhu H., Xu C.J., Yuan J.Y. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
58. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
59. Irmler M., Thome M., Hahne M., et al. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
60. Liston P., Roy N., Tamai K., et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 379:1996;349-353.
61. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
62. Deveraux Q.L., Roy N., Stennicke H.R., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:1998;2215-2223.
63. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-kappaB antiapoptosis:induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase 8 activation. Science. 281:1998;1680-1683.
64. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arteriscler Thromb Vasc Biol. 17:1997;2200-2208.
65. Baker A.H., Zaltsman A.B., George S.J., Newby A.C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro-TIMP-3 promotes apoptosis. J Clin Invest. 101:1998;1478-1487.
66. Bennett M., Macdonald K., Chan S.-W., et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 282:1998;290-293.
67. Fukuo K., Nakahashi T., Nomura S., et al. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology. 43:1997;35-42.
68. Hoffmann G., Kenn S., Wirleitner B., et al. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiology. 199:1998;63-73.
69. Fukuo K., Hata S., Suhara T., et al. Nitric oxide induces up regulation of fas and apoptosis in vascular smooth muscle. Hypertension. 27:1996;823-826.
70. Boyle J.J., Bowyer D.E., Weissberg P.L., Bennett M.R. Interactions between TNF alpha and nitric oxide in human macrophage- induced vascular smooth muscle cell apoptosis. J Pathol. 187:1999;A12.
71. Pollman M.J., Yamada T., Horiuchi M., Gibbons G.H. Vasoactive substances regulate vascular smooth-muscle cell apoptosis-countervailing influences of nitric-oxide and angiotensin-ii. Circ Res. 79:1996;748-756.
72. Zhao Z.H., Francis C.E., Welch G., Loscalzo J., Ravid K. Reduced glutathione prevents nitric oxide-induced apoptosis in vascular smooth muscle cells. Biochim Biophys Acta. 1359:1997;143-152.
73. Li P.F., Dietz R., vonHarsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 96:1997;3602-3609.
74. Nishio E., Watanabe Y. NO induced apoptosis accompanying the change of oncoprotein expression and the activation of CPP32 protease. Life Sci. 62:1997;239-245.
75. Iwashina M., Shichiri M., Marumo F., Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation. 98:1998;1212-1218.
76. Wang H., Keiser J.A. Molecular characterization of rabbit CPP32 and its function in vascular smooth muscle cell apoptosis. Am J Physiol. 43:1998;H1132-H1140.
77. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 95:1995;2266-2274.
78. Bochaton-Piallat M.-L., Ropraz P., Gabbiani F., Gabbiani G. Phenotypic heterogeneity of rat aortic smooth muscle cell clones. Arterioscler Thromb Vasc Biol. 16:1996;815-820.
79. Chan S., Weissberg P., Bennett M. Heterogeneity of caspase regulation of human vascular smooth muscle cell apoptosis. Heart. 71:1998;12. (Abstract).
80. Fox J., Shanley J. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem. 271:1996;12578-12584.
81. Miyamoto T., Leconte I., Swain J.L., et al. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro. J Cell Physiol. 177:1998;58-67.
82. Neschis D.G., Safford S.D., Hanna A.K., Fox J.C., Golden M.A. Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model. J Vasc Surg. 27:1998;126-134.
83. Shaulian E., Resnitzky D., Shifman O., et al. Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene. 15:1997;2717-2725.
84. Konstadoulakis M.M., Kymionis G.D., Karagiani M., et al. Evidence of apoptosis in human carotid atheroma. J Vasc Surg. 27:1998;733-739.
85. Kockx M.M., DeMeyer G.Y., Buyssens N., et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 83:1998;378-387.
86. Igase M., Okura T., Kitami Y., Hiwada K. Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries. Clin Sci. 96:1999;605-612.
87. Erl W., Hansson G., de Martin R., et al. Nuclear factor-κβ regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 84:1999;668-677.
88. Krajewska M., Wang H.G., Krajewski S., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57:1997;1605-1613.
89. Bennett M.R., Littlewood T.D., Schwartz S.M., Weissberg P.L. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis. Circ Res. 81:1997;591-599.
90. Yonish R.E., Grunwald D., Wilder S., et al. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol. 13:1993;1415-1423.
91. Johnson N., Gardner A., Diener K., et al. Signal-transduction pathways regulated by mitogen-activated extracellular response kinase kinase kinase induce cell-death. J Biol Chem. 271:1996;3229-3237.
92. Kauffman Zeh A., RodriguezViciana P., Ulrich E., et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI3K and PKB. Nature. 385:1997;544-548.
93. Meikrantz W., Gisselbrecht S., Tam S.W., Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA. 91:1994;3754-3758.
94. kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of a caspase cascade. Mol Cell. 1:1998;553-563.
95. Phillips A.C., Bates S., Ryan K.M., Helin K., Vousden K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11:1997;1853-1863.
96. Hsieh J.K., Fredersdorf S., Kouzarides T., Martin K., Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11:1997;1840-1852.
97. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA. 94:1997;7245-7250.
98. Bennett M.R., Evan G.I., Newby A.C. Deregulated c-myc oncogene expression blocks vascular smooth muscle cell inhibition mediated by heparin, interferon-γ, mitogen depletion and cyclic nucleotide analogues and induces apoptotic cell death. Circ Res. 74:1994;525-536.
99. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 77:1995;266-273.
100. Hueber A.O., Evan G.I. Traps to catch unwary oncogenes. Trends Genet. 14:1998;364-367.
101. Okura T., Igase M., Kitami Y., et al. Platelet-derived growth factor induces apoptosis in vascular smooth muscle cells: roles of the Bcl-2 family. Biochim Biophys Acta. 1403:1998;245-253.
102. Bennett M., Macdonald K., Chan S., Boyle J., Weissberg P. Co-operative interactions between RB and p53 regulate cell proliferation, cell senescence and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 82:1998;704-712.
103. Yonemitsu Y., Kaneda Y., Tanaka S., et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res. 82:1998;147-156.
104. Scheinman M., Ascher E., Levi G.S., et al. p53 gene transfer to the injured rat carotid artery decreases neointimal formation. J Vasc Surg. 29:1999;360-369.
105. Katayose D., Wersto R., Cowan K., Seth P. Consequences of p53 gene-expression by adenovirus vector on cell-cycle arrest and apoptosis in human aortic vascular smooth-muscle cells. Biochem Biophys Res Comm. 215:1995;446-451.
106. Ihling C., Menzel G., Wellens E., et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol. 17:1997;2218-2224.
107. Guevara N., Kim H.-S., Antonova E., Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 5:1999;335-339.